San Jose, CA
Sector: Semiconductors
Achronix builds the world's fastest field programmable gate arrays (FPGAs) which use a unique, patented circuit technology, providing 2GHz throughput; a significant performance advantage over existing FPGA technology. Applications for Achronix FPGAs include communications, networking, high performance computing, digital signal processing, aerospace and defense systems, medical imaging, and a growing range of other areas.
www.achronix.com
Providence, RI
Sector: Medical Devices
Afferent Corporation is pioneering the development of a new class of medical devices to treat chronic neurologic dysfunction. Its lead technology enhances the function of mechanoreceptor cells involved in sensory perception as a means to restore brain function following stroke, to address complications resulting from diabetic neuropathy, and to improve elderly balance.
www.afferentcorp.com
North Billerica, MA
Sector: Pharmaceutical Tools and Services
Serving the life sciences industry for over 20 years, Seahorse Bioscience provides industry-leading instruments and consumable labware products for biological research and drug discovery. Our customers include scientists at academic institutions, pharmaceutical and biotech organizations, as well as OEM manufacturers of assay kits and lab instruments suppliers.
www.seahorsebio.com
China
Sector: Systems and Software
Boro Networks designs, develops and markets state of the art IP-PBX systems and Voice-over-IP (VoIP) networking solutions specifically for the Chinese market. Not only does Boro offer the highest quality systems in the industry, but Boro differentiates itself from the competitors along those dimensions which are the most crucial to China’s fast growing medium and large enterprise customers.
Eden Prairie, MN
Sector: Medical Device
Celleration develops and markets proprietary technology that has been proven to accelerate healing in chronic and hard-to-heal wounds by delivering therapeutic, low frequency ultrasound without direct contact of the delivery device to the wound surface. Its core product offering, the MIST Therapy System has been clinically shown to positively impact all critical aspects of the wound healing process.
www.celleration.com
Philadelphia, PA
Sector: Pharmaceutical Therapeutics
Ception Therapeutics is focused on the discovery and development of novel products to address unmet medical needs in inflammatory, infectious and vascular diseases. The Company's pipeline includes a clinical-stage anti IL-5 monoclonal antibody targeting eosinophilic esophagitis and other eosinophil mediated inflammatory indications. Its preclinical programs include anti -TNF, anti-infective, and anti-thrombotic programs.
www.ceptiontherapeutics.com
Santa Barbera, CA
Sector: Pharmaceutical Therapeutics
Chimeros, Inc. is a cancer therapeutics company focused on the development of novel targeted treatments while generating immediate revenues from licensing platform rights and development contracts. Chimeros leverages its diverse scientific team to formulate novel therapeutics. Their technology will lead to improved methods for combating aggressive cancers of the lymphatic system that afflict children and elderly. Chimero's products will address a large market potential by improving the safety and efficacy of current therapeutics.
www.chimeros.com
Menlo Park, CA
Sector: Medical Device
Developer of innovative, controlled, drug eluting stents (DES) to treat coronary artery disease. Through a merger completed on February 1, 2007, Conor Medsystems, LLC became a wholly owned subsidiary of Johnson & Johnson, the world's most comprehensive and broadly based manufacturer of healthcare products.
www.conormed.com
Sunnyvale, CA
Sector: Medical Device
FlowCardia designs and develops innovative technologies to facilitate the crossing of totally occluded coronary and peripheral arteries. Chronic Total Occlusions (CTOs) are considered one of the last major clinical challenges in interventional therapy. The historic absence of safe and effective CTO recanalization devices and high restenosis rates of bare metal stents in CTOs have been major reasons the majority of CTO patients are still referred to medical management and bypass surgery.
www.flowcardia.com
New Haven, CT
Sector: Pharmaceutical Tools and Services
Ikonisys develops, commercializes and markets a digital microscopy platform and proprietary diagnostic applications that increase throughput and improve the accuracy of diagnostic screening in the areas of cancer diagnosis and management, prenatal detection of genetic disorders and fertility. The Company has developed two product lines, oncoFISH™ for cancer diagnostics and monitoring and fastFISH® for the prenatal detection of genetic disorders, which are designed to run on the company's proprietary Ikoniscope robotic digital microscopy platform.
www.ikonisys.com
Snoqualmie, WA
Sector: Medical Device
Light Sciences Oncology is developing Light Infusion Therapy (Litx™), an innovative light-activated treatment for solid tumors. LSO is currently developing Litx™ for the treatment of patients with cancers such as hepatoma, metastatic colorectal cancer and glioma, for which the current therapeutic alternatives are of limited efficacy. Litx™ has been designed to treat a wide range of solid tumors, including previously treated or untreatable tumors, and to be used repeatedly throughout a patient's life as needed.
www.lsoncology.com
Manchester, UK
Sector: Pharmaceutical Tools and Services
Oxyrane is leveraging its unique library of yeast organisms in the fields of chiral chemistry, biocatalysis, and the production of therapeutic proteins.
www.oxyrane.com
China
Sector: Systems and Software
Payzy enables customers to both make payments with their mobile phone and receive customized offers from merchants that can be redeemed at the cash register.
Palo Alto, CA
Sector: Pharmaceutical Therapuetics
Symphogen is the leader in developing recombinant polyclonal antibodies (rpAb), a new class of biopharmaceuticals for the treatment or prophylaxis of serious human diseases. By employing its pioneering antibody discovery and manufacturing technologies, Symphogen generates recombinant antibody compositions that capture the diversity and effectiveness of the natural immune system. Symphogen’s pipeline of product candidates and development programs address large and growing markets, such as the replacement of plasma-derived immunoglobulins, oncology, and a broad range of infectious diseases.
www.symphogen.com
Nagpur, India
Sector: Semiconductors and Components
RF Arrays provides innovative design and products at competitive costs by leveraging unique design talent and a high productivity work force available in India. Initial product focus includes RF Integrated Circuits and Modules, WLan / WiFi / WiMax, Wireless Audio and Video Streaming to Remote Sensing and Power Management.
www.rfarrays.com
Austin, TX
Sector: Semiconductors and Components
Silicon Space Technolgy designs solutions to eliminate the effect of radiation on semiconductors.
Allentown, PA
Sector: Semiconductors and Components
Lightwire is a fabless photonics start-up company. Its mission is to provide best in class, low power, low cost, next generation interconnect solutions using CMOS optoelectronics.
www.lightwire.com
Irvine, CA
Sector: Pharmaceutical Therapeutics
Therox has developed a treament for heart attacks by dissolving and stabilizing hyper-elevated concentrations of oxygen in saline solution. A small amount of the saline solution is then mixed with the patient's blood to create SuperOxygenated blood, which is infused through a catheter to oxygen deficient or ischemic tissue. Company research has confirmed in pre-clinical studies that SuperOxygenation Therapy can reverse ischemia and resuscitate tissue that would otherwise die.
www.therox.com
Freemont, CA
Sector: Medical Device
Xoft is revolutionizing the practice of radiation oncology through electronic brachytherapy with its proprietary miniaturized x-ray tube technology. It's first product, the Axxent™ Electronic Brachytherapy System applies radiation directly to a tumor bed within the body without the use of radioactive isotopes, heavy shielding, or major capital equipment.
www.xoftmicrotube.com
Cambridge, MA
Sector: Systems and Software
BioScale, Inc. is a life science tools company that has developed a powerful proprietary platform for life sciences and diagnostics. The Company’s products enable ultra-sensitive quantitative measurements scaling a wide range of biological analytes and complex matrices. BioScale’s BioMEMS-based Acoustic Membrane and Microparticle (AMMP™) technology provides picogram level detection that outperforms the existing “gold standard”. BioScale will launch AMMP technology in the bioprocessing and life sciences markets and plans to partner for diagnostic applications.
www.bioscale.com
Waltham, MA
Sector: Pharmaceutical Therapeutics
BioVex is a biotechnology company focues on targeted treatments for cancer and the prevention of infectious disease. Its clinical stage compound, OncoVEX, has the potential to establish a new standard of care in solid tumors by improving overal survival rates while minimizing side effects. Its lead infectious disease product candidate is ImmunoVEX HSV2, a vaccine for genital herpes.
www.biovex.com
Leesburg, VA
Sector: Medical Device
K2M will strive to be at the frontier of technological innovation, and through physician involvement from industry leaders, the Company will develop the highest quality products for surgeons with the ultimate purpose of promoting the well-being of patients with spinal disorders.
www.k2m.com
|
